PAREXEL RECIST 1.1 12+
PAREXEL International Corporation
Designed for iPad
-
- Free
Screenshots
Description
Learn about RECIST 1.1 and how it can be applied to your clinical trial.
RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.
What’s New
Version 2.0.1
Improved RECIST calculations which includes percent changes from Nadir.
User can enter Baseline and up to 9 follow up time points.
Target lesion measurements can be designated as lymph nodes.
Ratings and Reviews
App Privacy
The developer, PAREXEL International Corporation, has not provided details about its privacy practices and handling of data to Apple.
No Details Provided
The developer will be required to provide privacy details when they submit their next app update.
Information
- Seller
- PAREXEL International Corporation
- Size
- 8 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 8.0 or later.
- iPad
- Requires iPadOS 8.0 or later.
- iPod touch
- Requires iOS 8.0 or later.
- Mac
- Requires macOS 11 or later and a Mac with Apple M1 chip.
- Languages
-
English
- Age Rating
- 12+ Infrequent/Mild Medical/Treatment Information
- Copyright
- © PAREXEL Informatics
- Price
- Free
Supports
-
Family Sharing
With Family Sharing set up, up to six family members can use this app.